Welcome to FOODPOLIS

28
11월

November news updates on the Korea National Food Cluster’s resident companies

November news updates on

the Korea National Food Cluster’s resident companies

 

영문-타이틀

 

Jack Frost is already in action in November. But the cold can never stop the vigorous activities of companies in the Korea National Food Cluster. Here are November news updates on the Korea National Food Cluster’s resident companies.

 

Sunsu Bon Co. Takes the Food Processing Practice Course at Iksan Campus of Korea Polytechnic

 

20171122125935956021

▲ Source: Nocut News

 

Sunsu Bon Co. a member company of the Korea National Food Cluster will take the course of Food Processing Practice under local and industry-customized talents nurturing project at Iksan Campus of Korea Polytechnic. This is the first time that a member company of the cluster to participate in the educational course. Sunsu Bon Co. signed an MOU with Iksan Campus of Korea Polytechnic.

Local and industry-customized talent nurturing project is an educational and training project with 100% government subsidy for tuition. It is aimed to respond to industrial and business needs of local community, by educating and training the unemployed and employed workers

19 members will take the Food Processing Practice course for a month and will take a test to decide whether Sunsu Bon. passes the course. The 19 members expressed their strong commitment to making it to successful completion of the course.

 

GenoFocus challenges the health functional food market

 

3

▲ Source: Dailypharm

 

Having finished the development of enzyme technology for foods, health functional foods and medicines, customized enzyme product specialist GenoFocus is aiming to advance into the health functional food market. Armed with molecular evolution and protein expression technologies, the company produces improved enzymes using microorganisms.

In particular, GenoFocus is a supplier of environmentally-friendly Catalase enzyme to the world’s biggest semiconductor company. Catalase and other products marked annual revenues of seven billion won last year, and the company is recognized in overseas markets for its excellence in technology.

In addition, GenoFocus is about to launch a product named “Biwooja Jang,” which contains immune booster GOS found in mother’s milk. The company’s enzyme-based food and health functional food products are sold online, and the company aims to further widen its distribution channel to offline markets with the launch of Biwooja Jang.

 

Dorsetgoal Food&C concludes an agricultural product sales promotion agreement with Iksan Horticultural Cooperative

 

1173578_301924_4818

▲ Source: iksanwonhyup

 

Dorsetgoal Food&C, a resident company of the Korea National Food Cluster and maker of kimchi, signed an agreement with Iksan Horticultural Cooperative on the promotion of agricultural product sales. Aiming to increase the sales of agricultural products, Iksan Horticultural Cooperative was looking for a reciprocal partner from the Korea National Food Cluster. They finally chose Dorsetgoal Food&C and signed the purchase agreement.

Under this agreement, Dorsetgoal Food&C and Iksan Horticultural Cooperative will join hands in supplying agricultural products and other ingredients to increase the sales of agricultural products. Dorsetgoal’s processed food products will be marketed through various distribution channels including Iksan Horticultural Cooperative’s stores.

An official of Iksan Horticultural Cooperative encouraged the local company and expressed his anticipation that this agreement will help Dorsetgoal Food&C strengthen its presence in the market.

 

Bio Leaders applies for FDA Orphan Drug Designation for DMD treatment

 

5

▲ Source: Bio Leaders website

 

Bio Leaders applied for an FDA Orphan Drug Designation for BLS-M22, a treatment for Duchenne Muscular Dystrophy, or DMD. BLS-M22 is anticipating initial clinical trials.

DMD is a genetic disease primarily seen in boys and involves muscular dystrophy in the proximal areas close to the torso. There is no proven treatment for DMD.

The Bio Leaders BLS-M22’s treatment mechanism is designed to promote muscular formation. Being designated as an FDA Orphan Drug means exclusive marketing rights guaranteed for seven years and benefits including tax exemption and research grants.

 

business, office, law and legal concept - picture of man and woman hand signing contract paper

 

November was yet another busy month for the resident companies of the Korea National Food Cluster, and they are anticipating a memorable end of the year in December. They are exerting their utmost efforts to play their roles as food companies behind the scene. And they are looking forward to your continued interests and support!

About foodpolis

Leave a Reply

이메일은 공개되지 않습니다. 필수 입력창은 * 로 표시되어 있습니다.